Thesis
Catalyzing breakthrough science into transformational biotech, life science, and deep tech companies from the earliest stage.
Stages
GrowthPre-SeedSeedSeries ASeries B
Sectors
BiotechLife SciencesDeep Tech/Hard ScienceHealthcare/Medtech
Fund
- Current fund
- ARCH Venture Fund XIII · 2024 · $$3B+
- AUM
- $$12B+
- Check size
- $50K – $100M
